Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    16106158 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Acellular Dermal Matrix in Tissue Expander Breast Reconstruction: A Prospective, Randomized, Clinical Trial Comparing SurgiMend PRS and AlloDerm RTU
Conditions: Breast Cancer;   Mastectomy
Interventions: Device: AlloDerm RTU;   Device: SurgiMend PRS
2 Recruiting SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial
Condition: Breast Neoplasms
Interventions: Device: SurgiMend® Acellular Dermal Matrix;   Device: Strattice™ Acellular Dermal Matrix

Study has passed its completion date and status has not been verified in more than two years.